Clinical Trial Protocol for Safety and Efficacy of Transcatheter Ablation After Left Atrial Appendicular Occlusion With WATCHMAN FLX
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
Objective: To evaluate the safety and efficacy of transcatheter atrial fibrillation ablation 1 month after WATCHMAN FLX left atrial appendage closure in patients with nonvalvular atrial fibrillation.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• ≥18 years of age, diagnosed with nonvalvular atrial fibrillation;
• Meet the indications for receiving WATCHMAN FLX left atrial appendicular closure and transcatheter atrial fibrillation ablation;
• Preoperative imaging evaluation showed that the anatomical structure of the left atrial appendage was suitable for implantation with the WATCHMAN FLX device;
• The patient agrees to participate in the study and signs the informed consent.
Locations
Other Locations
China
Affiliated hospital of Nantong University
RECRUITING
Nantong
Contact Information
Primary
Qi Lu MD
luqint@sina.com
+8613962989292
Backup
Jian Zhang MD
13776926152
Time Frame
Start Date: 2025-04-21
Estimated Completion Date: 2028-06-01
Participants
Target number of participants: 210
Treatments
Experimental group
Patients who meet the diagnosis of non-valvular atrial fibrillation and plan to receive sequential treatment of WATCHMAN FLX left atrial appendage occlusion and transcatheter atrial fibrillation ablation.
Related Therapeutic Areas
Sponsors
Leads: Affiliated Hospital of Nantong University